MESO
USDMesoblast Limited American Depositary Shares
$11.870-0.180 (-1.494%)
Real-time Price
Healthcare
Biotechnology
Australia
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$12.050
High
$12.430
Low
$11.910
Volume
0.04M
Company Fundamentals
Market Cap
1.5B
Industry
Biotechnology
Country
Australia
Trading Stats
Avg Volume
0.22M
Exchange
NMS
Currency
USD
52-Week Range
Low $5.78Current $11.870High $22
Related News
GlobeNewswire
Mesoblast Maintains Momentum With FDA on Accelerated Approval Pathway for Revascor® in Ischemic Heart Failure and Label Extension for Ryoncil® in Adults With GvHD
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Mesoblast (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on continued momentum with United States
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.